KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Invested Capital (2017 - 2025)

Historic Invested Capital for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$354.5 million.

  • Guardant Health's Invested Capital fell 48984.46% to -$354.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$354.5 million, marking a year-over-year decrease of 48984.46%. This contributed to the annual value of -$139.6 million for FY2024, which is 18800.32% down from last year.
  • Latest data reveals that Guardant Health reported Invested Capital of -$354.5 million as of Q3 2025, which was down 48984.46% from -$305.5 million recorded in Q2 2025.
  • Guardant Health's Invested Capital's 5-year high stood at $847.0 million during Q1 2021, with a 5-year trough of -$354.5 million in Q3 2025.
  • For the 5-year period, Guardant Health's Invested Capital averaged around $192.6 million, with its median value being $158.7 million (2023).
  • Its Invested Capital has fluctuated over the past 5 years, first surged by 25327.38% in 2024, then crashed by 1883831.37% in 2025.
  • Quarter analysis of 5 years shows Guardant Health's Invested Capital stood at $645.0 million in 2021, then tumbled by 90.67% to $60.2 million in 2022, then skyrocketed by 163.68% to $158.7 million in 2023, then crashed by 188.0% to -$139.6 million in 2024, then tumbled by 153.84% to -$354.5 million in 2025.
  • Its last three reported values are -$354.5 million in Q3 2025, -$305.5 million for Q2 2025, and -$250.8 million during Q1 2025.